FASS logotyp
Receptbelagd

Peka på symbolerna och beteckningarna till vänster för en förklaring.

Kontakt

Sök apotek med läkemedlet i lager

Sök lagerstatus

Propavan

Sanofi AB

Tablett 25 mg
(Vita till gulvita, runda, kupade tabletter med brytskåra på ena sidan, diameter 9 mm.)

Sömnmedel

Aktiv substans:
ATC-kod: N05CM06
Läkemedel från Sanofi AB omfattas av Läkemedelsförsäkringen.
  • Vad är miljöinformation?

Miljöinformation

Miljöpåverkan

Propiomazin

Miljörisk: Risk för miljöpåverkan av propiomazin kan inte uteslutas då ekotoxikologiska data saknas.
Nedbrytning: Det kan inte uteslutas att propiomazin är persistent, då data saknas.
Bioackumulering: Propiomazin har hög potential att bioackumuleras.


Läs mer

Detaljerad miljöinformation


Environmental risk classification

Predicted environmental concentration (PEC)

PEC is calculated according to the following formula:

PEC (µg/L) = (A*109(100-R))/(365*P*V*D*100) = 1.37*10-6A*(100-R)


PEC = 0.207 µg/L


Where:

A = 1507.51 kg (total sold amount API in Sweden year 2020, data from IQVIA)

R = 0 % removal rate (due to loss by adsorption to sludge particles, by

volatilization, hydrolysis or biodegradation) = 0 if no data is available.

P = number of inhabitants in Sweden = 10*106

V (L/day) = volume of wastewater per capita and day = 200 (ECHA default) (Ref. I)

D = factor of dilution of waste water by surface water flow = 10 (ECHA default) (Ref. I)


Predicted no effect concentration (PNEC)

Ecotoxicological studies

No data is available.


Environmental risk classification (PEC/PNEC ratio)

The PEC/PNEC ratio could not be determined since no ecotoxicological test results are available.


Justification of chosen summary phrases for the environmental risk:

Risk of environmental impact of propiomazine cannot be excluded, since no ecotoxicity data are available.


Degradation

No degradation data is available.

Justification of chosen degradation phrase:
The potential for persistence of propiomazine cannot be excluded, due to lack of data.


Bioaccumulation

log P = 4.79 (experimentally determined, BIOBYTE (1995))
(Ref. II)


Justification of chosen bioaccumulation phrase:
Since log P > 4, propiomazine has high potential for bioaccumulation.


Excretion (metabolism)
Metabolism: Unknown, but most likely hepatic as with other phenothiazines.
Elimination: Not available.
(Ref. II)

No full picture of metabolites publicly available.


References

  1. ECHA, European Chemicals Agency. 2008 Guidance on information requirements and chemical safety assessment; find here.

  2. Propiomazine at Drug Bank, retrieved 2021-12-09 from Drug Bank.com; find here.